Neal Koller - Perthera, Inc.

Team Member

President and CEO

Mr. Neal Koller is President and CEO of Perthera, Inc. Through his prior senior executive positions at global pharmaceutical and healthcare companies, Mr. Koller brings extensive skills in business and corporate growth. He has operational management and leadership experience in both small and large companies, and risk oversight and management from wide-ranging responsibilities in pharmaceutical and medical device industries.

Prior to Perthera, Mr. Koller held the responsibility of President & CEO at PluroGen Therapeutics, LLC., where he was the first employee. He opened its manufacturing and operations facility and launched products into both the US and international markets. Mr Koller exited Plurogen to a private multi-national medical device company. Mr. Koller also previously held positions as the President of the Parenteral Drug Association which was preceded by his responsibilities as CEO of Sound Diagnostics Inc., President and CEO of Dovetail Technologies Inc., and President of WelCare International Corporation.

Mr. Koller started his career in a division of Searle Pharmaceuticals which was acquired by Wyeth Pharmaceuticals. Through increasing responsibilities, Mr. Koller made notable contributions over his 18 years with the company. He served as division head for two start-up divisions which he successfully exited, was Vice President of Business Development, and was Vice President of the Operating Room/Critical Care Division where he doubled earnings and introduced a large portfolio of new products.

Koller holds a BS in Biology from the University of Richmond.